BIOLOGICAL CORRELATES OF QUALITY OF SURVIVAL AND NEUROCOGNITIVE OUTCOMES IN MEDULLOBLASTOMA; A META-ANALYSIS OF THE SIOP-UKCCSG-PNET3 AND HIT-SIOP-PNET4 TRIALS

被引：0
|
作者：
Chevignard, Mathilde [1 ]
Bull, Kim [2 ]
Holt, James [3 ]
Heng, Marie-Amelie [4 ]
Kennedy, Colin [2 ]
Doz, Francois [5 ]
Lannering, Birgitta [6 ]
Rutkowski, Stefan [7 ]
Massimino, Maura [8 ]
Clifford, Steven [3 ]
Hicks, Debbie [3 ]
机构：
[1] St Maurice Hosp, St Maurice, France
[2] Univ Southampton, Southampton, Hants, England
[3] Newcastle Univ, Ctr Canc, Newcastle Upon Tyne, Tyne & Wear, England
[4] Inst Curie, Paris, France
[5] Inst Curie, Paris, France
[6] Univ Gothenburg, Gothenburg, Sweden
[7] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[8] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
QOL-17
引用
下载
收藏
页码：434 / 434
页数：1
相关论文
共 13 条
  • [1] CLINICO-MOLECULAR CORRELATES OF QUALITY OF SURVIVAL AND NEUROCOGNITIVE OUTCOMES IN MEDULLOBLASTOMA; A META-ANALYSIS OF THE SIOP-UKCCSG-PNET3 AND HIT-SIOP-PNET4 TRIALS
    Chevignard, Mathilde
    Bull, Kim S.
    Holt, James
    Harrington, Bertie
    Castle, Jemma
    Heng, Marie-Amelie
    Kennedy, Colin
    Doz, Francois
    Lannering, Birgitta
    Rutkowski, Stefan
    Massimino, Maura
    Bailey, Simon
    Oyefiade, Adeoye
    Mabbott, Donald
    Clifford, Steven C.
    Hicks, Debbie
    NEURO-ONCOLOGY, 2022, 24 : 139 - 140
  • [2] Medulloblastoma Survivorship Outcomes are Related to Tumour Molecular Subgroup; A Meta-Analysis of the SIOP-UKCCSG-PNET3 and HIT-SIOP-PNET4 Trials
    Chevignard, M.
    Bull, K.
    Heng, M. A.
    Kennedy, C.
    Doz, F.
    Lannering, B.
    Rutkowski, S.
    Massimino, M.
    Clifford, S.
    Hicks, D.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S39 - S39
  • [3] Treatment Outcomes of Childhood Medulloblastoma with the SIOP/UKCCSG PNET-3 Protocol
    Kartal, Ibrahim
    Dagdemir, Ayhan
    Dincer, Oguz Salih
    Simsek, Hulya Kangal
    Uygun, Alper
    Gursel, Suekriye Bilge
    INDIAN JOURNAL OF PEDIATRICS, 2023, 90 (11): : 1116 - 1122
  • [4] Treatment Outcomes of Childhood Medulloblastoma with the SIOP/UKCCSG PNET-3 Protocol
    İbrahim Kartal
    Ayhan Dağdemir
    Oğuz Salih Dinçer
    Hülya Kangal Şimşek
    Alper Uygun
    Şükriye Bilge Gürsel
    Indian Journal of Pediatrics, 2023, 90 : 1116 - 1122
  • [5] Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study
    Sabel, Magnus
    Fleischhack, Gudrun
    Tippelt, Stephan
    Gustafsson, Goran
    Doz, Francois
    Kortmann, Rolf
    Massimino, Maura
    Navajas, Aurora
    von Hoff, Katja
    Rutkowski, Stefan
    Warmuth-Metz, Monika
    Clifford, Steven C.
    Pietsch, Torsten
    Pizer, Barry
    Lannering, Birgitta
    JOURNAL OF NEURO-ONCOLOGY, 2016, 129 (03) : 515 - 524
  • [6] Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study
    Magnus Sabel
    Gudrun Fleischhack
    Stephan Tippelt
    Göran Gustafsson
    François Doz
    Rolf Kortmann
    Maura Massimino
    Aurora Navajas
    Katja von Hoff
    Stefan Rutkowski
    Monika Warmuth-Metz
    Steven C. Clifford
    Torsten Pietsch
    Barry Pizer
    Birgitta Lannering
    Journal of Neuro-Oncology, 2016, 129 : 515 - 524
  • [7] HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN HIT-SIOP-PNET4 TRIAL SURVIVORS: DIFFERENCES BETWEEN MEDULLOBLASTOMA MOLECULAR SUBGROUPS
    Bull, Kim
    Kennedy, Colin
    Schwalbe, Ed
    Hicks, Debbie
    Doz, Francois
    Rutkowski, Stefan
    Lannering, Birgitta
    Pietsch, Torsten
    Clifford, Steven
    NEURO-ONCOLOGY, 2016, 18 : 150 - 151
  • [8] Improved health-related quality of life outcomes associated with SHH subgroup medulloblastoma in SIOP-UKCCSG PNET3 trial survivors
    Kim S. Bull
    Colin R. Kennedy
    Simon Bailey
    David W. Ellison
    Steven C. Clifford
    Acta Neuropathologica, 2014, 128 : 151 - 153
  • [9] Improved health-related quality of life outcomes associated with SHH subgroup medulloblastoma in SIOP-UKCCSG PNET3 trial survivors
    Bull, Kim S.
    Kennedy, Colin R.
    Bailey, Simon
    Ellison, David W.
    Clifford, Steven C.
    ACTA NEUROPATHOLOGICA, 2014, 128 (01) : 151 - 153
  • [10] Whole chromosomal aberration signatures predict survival in standard-risk non-WNT/non-SHH medulloblastoma: Molecular analysis of the HIT-SIOP-PNET4 clinical trial
    Pietsch, Torsten
    Goschzik, Tobias
    Schwalbe, Edward C.
    Hicks, Debbie
    Williamson, Daniel
    Figarella, Dominique
    Doz, Francois
    Rutkowski, Stefan
    Lannering, Birgitta
    Clifford, Steven C.
    BRAIN PATHOLOGY, 2019, 29 : 186 - 186
12